ARTICLE | Company News
Kinexis, Merck neurological deal
July 21, 2003 7:00 AM UTC
The companies partnered to validate and screen small molecules against a prokineticin receptor target from Kinexis (Carlsbad, Calif.), for use in developing CNS therapeutics. Kinexis will receive rese...